Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose QBW251 in COPD with chronic bronchitis
2014-001530-28Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) comparing QBW251 arm with Placebo arm (2 arms). Primary endpoint: Change in LCI from Baseline to Day 29. Started Mar 2016; status: completed.
02
Drugs
Icenticaftor
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on 2014-001530-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001530-28.